Literature DB >> 29988271

Histopathologic Evaluation of Hyaluronic Acid and Plasma-Rich Platelet Injection into Rabbit Vocal Cords: An Experimental Study.

Selmin Karataylı Özgürsoy1, Fatma Tunçkaşık1, M Emin Tunçkaşık2, Egemen Akıncıoğlu3, Handan Doğan4, Güçlü Kaan Beriat1.   

Abstract

OBJECTIVE: Various materials are used by otolaryngologists for vocal cord injections in the management of vocal cord paralysis. An ideal injection material should be long-term effective, readily available, cheap, easy to prepare, have no donor morbidity, easy to use, biocompatible, resistant to resorption or migration, and easy to extract during revision. In this study, we aimed to see the histopathological effects of hyaluronic acid (HYA) and platelet-rich plasma (PRP) injections into the vocal cords of New Zealand rabbits.
METHODS: PRP was injected into the right vocal cords of twelve rabbits, which was prepared from their serum (PRP group). HYA was injected into the left vocal cords of first six rabbits (numbered 1-6) (HYA group), and the left vocal cords of the other six rabbits (numbered 7-12) were followed with no intervention (control group). Two months later, histomorphological findings in the vocal cords were assessed by two experienced pathologists in seven parameters: chronic inflammation, mucosal atrophy, necrosis, neovascularization, fibrosis, foreign body reaction, and muscular atrophy. They were scored double-blinded as negative (0), mild (+1), moderate (+2), and severe (+3). Fisher's chi-square test was used to evaluate any statistical significance among the three groups.
RESULTS: Chronic inflammation, mucosal atrophy, necrosis, foreign body reaction, and muscular atrophy parameters were scored as "0" for each preparate by both pathologists. For neovascularization and fibrosis, a stasistically significant difference was seen among the three groups (p<0.05). Neovascularization was increased in the PRP and HYA groups compared with the control group. No significant difference was observed in fibrosis when the groups were compared separately. After two months, two of the six vocal cords injected with HYA revealed HYA; however, none of the PRP-injected vocal cords showed PRP.
CONCLUSION: HYA and PRP can be safely injected into vocal cords. Our findings show that HYA is a biocompatible and safe injection material for clinical use. Only two of the six vocal cords showed HYA at the end of two months, suggesting that HYA is a short-term effective material. Similarly, PRP was also shown to be a short-term effective material and can be used in patients for testing purpose before using a long-term effective material. The advantages of PRP are that it is inexpensive, readily available, and completely inert as it is prepared from the subject itself.

Entities:  

Keywords:  Vocal cord; hyaluronic acid; platelet-rich plasma; vocal cord paralysis

Year:  2018        PMID: 29988271      PMCID: PMC6017207          DOI: 10.5152/tao.2018.2942

Source DB:  PubMed          Journal:  Turk Arch Otorhinolaryngol        ISSN: 2667-7466


  27 in total

1.  Vocal rehabilitation of paralytic dysphonia. I. Cartilage injection into a paralyzed vocal cord.

Authors:  G E ARNOLD
Journal:  AMA Arch Otolaryngol       Date:  1955-07

2.  The use of autologous PRP gel as an aid in the management of acute trauma wounds.

Authors:  K Kazakos; D N Lyras; D Verettas; K Tilkeridis; M Tryfonidis
Journal:  Injury       Date:  2008-08-13       Impact factor: 2.586

3.  Platelet-rich plasma: Growth factor enhancement for bone grafts.

Authors:  R E Marx; E R Carlson; R M Eichstaedt; S R Schimmele; J E Strauss; K R Georgeff
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-06

4.  Intracordal polytef (Teflon) injection. Histologic study of three further cases.

Authors:  J W Stone; G E Arnold; C B Stephens
Journal:  Arch Otolaryngol       Date:  1970-06

5.  Misadventures with injectable polytef (Teflon).

Authors:  H J Rubin
Journal:  Arch Otolaryngol       Date:  1975-02

Review 6.  The use of platelet-rich plasma in plastic surgery: a systematic review.

Authors:  C E Sommeling; A Heyneman; H Hoeksema; J Verbelen; F B Stillaert; S Monstrey
Journal:  J Plast Reconstr Aesthet Surg       Date:  2012-12-11       Impact factor: 2.740

7.  Enhancement of vascularization and granulation tissue formation by growth factors in human platelet-rich plasma-containing fragmin/protamine microparticles.

Authors:  Megumi Takikawa; Shin-Ichiro Nakamura; Shingo Nakamura; Masaki Nambu; Masayuki Ishihara; Masanori Fujita; Satoko Kishimoto; Takashi Doumoto; Satoshi Yanagibayashi; Ryuichi Azuma; Naoto Yamamoto; Tomoharu Kiyosawa
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2011-03-22       Impact factor: 3.368

8.  Platelet-rich plasma versus platelet-poor plasma in the management of chronic diabetic foot ulcers: a comparative study.

Authors:  Hany Saad Setta; Ahmed Elshahat; Khalid Elsherbiny; Karim Massoud; Ikram Safe
Journal:  Int Wound J       Date:  2011-04-07       Impact factor: 3.315

9.  Polydimethylsiloxane versus polytetrafluoroethylene for vocal fold medialization: histologic evaluation in a rabbit model.

Authors:  Miguel Caballero; Manuel Bernal-Sprekelsen; Carlos Calvo; Xavier Farrè; Lorenc Quintó; Lucia Alòs
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2003-10-15       Impact factor: 3.368

10.  Favorable vocal fold wound healing induced by platelet-rich plasma injection.

Authors:  Seung Hoon Woo; Han-Sin Jeong; Jin Pyeong Kim; Eun-Ha Koh; Seon Uk Lee; Sung Min Jin; Dong Hoon Kim; Jin Hee Sohn; Sang Hyuk Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-02-05       Impact factor: 3.372

View more
  3 in total

1.  Autologous Fat Plus Platelet-Rich Plasma versus Autologous Fat Alone on Sulcus Vocalis.

Authors:  Yung-An Tsou; Vincent Hui-Chi Tien; Sheng-Hwa Chen; Liang-Chun Shih; Tzu-Chieh Lin; Chien-Jen Chiu; Wen-Dien Chang
Journal:  J Clin Med       Date:  2022-01-29       Impact factor: 4.241

2.  The Effect of Platelet-Rich Plasma Injection on Short Term Vocal Outcomes Following Phonosurgery-A Pilot Study.

Authors:  Laszlo Peter Ujvary; Magdalena Chirilă; Cristina Țiple; Alma Aurelia Maniu; Septimiu Sever Pop; Cristina Maria Blebea; Stefan Vesa; Marcel Cosgarea
Journal:  Medicina (Kaunas)       Date:  2022-07-25       Impact factor: 2.948

3.  Autologous Platelet- and Extracellular Vesicle-Rich Plasma Is an Effective Treatment Modality for Chronic Postoperative Temporal Bone Cavity Inflammation: Randomized Controlled Clinical Trial.

Authors:  Domen Vozel; Darja Božič; Marko Jeran; Zala Jan; Manca Pajnič; Ljubiša Pađen; Nejc Steiner; Veronika Kralj-Iglič; Saba Battelino
Journal:  Front Bioeng Biotechnol       Date:  2021-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.